{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-12-13T12:22:12.107645+00:00",
  "news": [
    {
      "title": "Amgen obesity marketing leader Chris Boulton takes reins at metabolic biotech Prolynx - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPdzduVzR5YzE1Mmh0YjYxMHBKY1lfb04zeGl6dFVudmdwUHh2cXFLQWM5Um5EMVM2blpJM2hzbjNFV0NIM190X29iczMteFJFVk9iMDlMb2prSGdLZWZpQ2NMRG5SOF9vdW84b0FoYXN3RHQ0UllVN3Z2NThCOTZkV3d2UlBtRmRsNDRTLTg1WVNnejdSWklnUUk3MnIyVHRaanR1TEhINGtmMjZPX2hwV05XM2RMeHlpcFJWOWVR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxPdzduVzR5YzE1Mmh0YjYxMHBKY1lfb04zeGl6dFVudmdwUHh2cXFLQWM5Um5EMVM2blpJM2hzbjNFV0NIM190X29iczMteFJFVk9iMDlMb2prSGdLZWZpQ2NMRG5SOF9vdW84b0FoYXN3RHQ0UllVN3Z2NThCOTZkV3d2UlBtRmRsNDRTLTg1WVNnejdSWklnUUk3MnIyVHRaanR1TEhINGtmMjZPX2hwV05XM2RMeHlpcFJWOWVR?oc=5\" target=\"_blank\">Amgen obesity marketing leader Chris Boulton takes reins at metabolic biotech Prolynx</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-12-11T15:40:00+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "FDA broadens label for Amgen’s Uplizna as it enters rare disease competition - Endpoints News",
      "link": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPYVhUUTB1eUxjVFpzRTdQeFVIZ2QzS2gwZC1SVEp4V3dNVFd2d1lkOUt0MmtiZFlpR0VsX3BtNjc4WU5GZ2t4TmJDU2dCUW1mcEhnWkp2TV9EVlc3TWNBVXhpTXc4SElIV2JIOGE4UkhBTjZHOS1RM3NMRy12eDNvNVZ2eVdkMTd6VmxSWWF6Zk9uaFZETTllWW5xMzlrQVds?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMioAFBVV95cUxPYVhUUTB1eUxjVFpzRTdQeFVIZ2QzS2gwZC1SVEp4V3dNVFd2d1lkOUt0MmtiZFlpR0VsX3BtNjc4WU5GZ2t4TmJDU2dCUW1mcEhnWkp2TV9EVlc3TWNBVXhpTXc4SElIV2JIOGE4UkhBTjZHOS1RM3NMRy12eDNvNVZ2eVdkMTd6VmxSWWF6Zk9uaFZETTllWW5xMzlrQVds?oc=5\" target=\"_blank\">FDA broadens label for Amgen’s Uplizna as it enters rare disease competition</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Endpoints News</font>",
      "published": "2025-12-12T12:03:00+00:00",
      "source": "Endpoints News"
    },
    {
      "title": "Amgen wins FDA approval for Uplizna in generalized myasthenia gravis - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMitgFBVV95cUxQcWJzZjZDUWcxSXdLbFhFNDItRG0zZjBMSU9FWjVCZjZQVTcwYy15QWllNk15SEpUay1RRmVDbFV6VGx2V3NzLW40cTYybjNFakpPZDdVWmxXeklBOE0wUjdzMXFjME1mdV9kMTVSRnZBUHhla1lXcFl0WG5DN1N0TEF1aFV4MFllN005V0paZTVNbk0yNHJYZ2JiMGFVNkt0Qlkya1kwS3NpdTFxVHJONUY3WDJPZw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMitgFBVV95cUxQcWJzZjZDUWcxSXdLbFhFNDItRG0zZjBMSU9FWjVCZjZQVTcwYy15QWllNk15SEpUay1RRmVDbFV6VGx2V3NzLW40cTYybjNFakpPZDdVWmxXeklBOE0wUjdzMXFjME1mdV9kMTVSRnZBUHhla1lXcFl0WG5DN1N0TEF1aFV4MFllN005V0paZTVNbk0yNHJYZ2JiMGFVNkt0Qlkya1kwS3NpdTFxVHJONUY3WDJPZw?oc=5\" target=\"_blank\">Amgen wins FDA approval for Uplizna in generalized myasthenia gravis</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2025-12-12T10:22:05+00:00",
      "source": "The Pharma Letter"
    },
    {
      "title": "In pursuit of ultra-long-acting obesity meds, Prolynx raises $70M, taps Amgen vet - FirstWord Pharma",
      "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1iUU5kc0R2U2tucWdnUGZMSEFhT3B0UVd6UVpXRlFXM1o1aVFOX21ycDhzZXlmazg3b0dlLXdqcldIejFra29XTWFpV2d5d0JfV3VV?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1iUU5kc0R2U2tucWdnUGZMSEFhT3B0UVd6UVpXRlFXM1o1aVFOX21ycDhzZXlmazg3b0dlLXdqcldIejFra29XTWFpV2d5d0JfV3VV?oc=5\" target=\"_blank\">In pursuit of ultra-long-acting obesity meds, Prolynx raises $70M, taps Amgen vet</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">FirstWord Pharma</font>",
      "published": "2025-12-11T20:03:45+00:00",
      "source": "FirstWord Pharma"
    },
    {
      "title": "Amgen Scores Uplizna Expansion Into Generalized Myasthenia Gravis - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQOWtNNTRCZXg3TS1zMUZac0JjS3REUFNJeDcweWJWc19sdXEzT19xTGRVOHUxODhZbllMYjhMLS10aVRoTHRUeXh3c3g1d3ZlakFyTVRXUTJSNHVuLTAxUmZYdUEyWHg3Slh0YWtxcFd1alJVUkt0Z2hGbnZTLTJDMDJsZGljQzgyd3AzQTdfV2E2M19Jem5FUXFn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxQOWtNNTRCZXg3TS1zMUZac0JjS3REUFNJeDcweWJWc19sdXEzT19xTGRVOHUxODhZbllMYjhMLS10aVRoTHRUeXh3c3g1d3ZlakFyTVRXUTJSNHVuLTAxUmZYdUEyWHg3Slh0YWtxcFd1alJVUkt0Z2hGbnZTLTJDMDJsZGljQzgyd3AzQTdfV2E2M19Jem5FUXFn?oc=5\" target=\"_blank\">Amgen Scores Uplizna Expansion Into Generalized Myasthenia Gravis</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-12-12T13:28:45+00:00",
      "source": "BioSpace"
    },
    {
      "title": "Amgen's Uplizna breaks into crowded myasthenia gravis market with FDA nod - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPdzdabm5oVWZTbklRTE1GUEdQWFNOTnFQOFdUZF9rU2FwZ1ZaRzJoZDdCS1hYdy1ZQUdUNXhSaUNfYmFjV2RjR3MzaTlRNkZSNU1wOHBYcXhkSmw4VUcxRDgzMktpcjk4YktMWmZUNzFCQXRMazJHMThUX2JMUGVOUnAyMWhJQlNQX19OUURxQ3A0dmVZc2dnN201WHJucnFndTdfZ0pB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipgFBVV95cUxPdzdabm5oVWZTbklRTE1GUEdQWFNOTnFQOFdUZF9rU2FwZ1ZaRzJoZDdCS1hYdy1ZQUdUNXhSaUNfYmFjV2RjR3MzaTlRNkZSNU1wOHBYcXhkSmw4VUcxRDgzMktpcjk4YktMWmZUNzFCQXRMazJHMThUX2JMUGVOUnAyMWhJQlNQX19OUURxQ3A0dmVZc2dnN201WHJucnFndTdfZ0pB?oc=5\" target=\"_blank\">Amgen's Uplizna breaks into crowded myasthenia gravis market with FDA nod</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-12-12T14:49:19+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "Amgen wins FDA nod for Uplizna in myasthenia gravis (AMGN) - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMiigFBVV95cUxQNkFvY3QzZnlZazJsYkNyX3RGb1VJU2JJNFRoTkRuLU1URFNqdWRoZm56ZFQxZVd4UkFBYmFGVHdTbkxzcm9SSmg5ai0yM3huTEh6T1dtYTZkNkFoX1V2WUJxbUxLdjJMakZ2b0lFdUtzSDZNajZObUlVYlppTkdNbmt3aHNWREFWSHc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiigFBVV95cUxQNkFvY3QzZnlZazJsYkNyX3RGb1VJU2JJNFRoTkRuLU1URFNqdWRoZm56ZFQxZVd4UkFBYmFGVHdTbkxzcm9SSmg5ai0yM3huTEh6T1dtYTZkNkFoX1V2WUJxbUxLdjJMakZ2b0lFdUtzSDZNajZObUlVYlppTkdNbmt3aHNWREFWSHc?oc=5\" target=\"_blank\">Amgen wins FDA nod for Uplizna in myasthenia gravis (AMGN)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-12-12T13:14:17+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Weight loss biotech gets $70M, snags Amgen's obesity commercial leader as CEO - Endpoints News",
      "link": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNdV9PQXd3ZEdQenZCSnJ0R2ZKcTZzMWVSdTNpZ1R3clh5V2I0Mk1FZGZ0d0pvYUhJazk3QjFkSjY5cmEzNjg4UFotWXRKTGNxN1hla3oxcFJGN0M5SWhQcTF2SHV3c25oMWZRcEl1bDB6cVN5V09zQTE1dllZYlhSTk03ME1EbGNZMndkb0FxZ2NjUTh5YkFvcnhNM2hrcXFIcVBVMmxIc2pHUQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNdV9PQXd3ZEdQenZCSnJ0R2ZKcTZzMWVSdTNpZ1R3clh5V2I0Mk1FZGZ0d0pvYUhJazk3QjFkSjY5cmEzNjg4UFotWXRKTGNxN1hla3oxcFJGN0M5SWhQcTF2SHV3c25oMWZRcEl1bDB6cVN5V09zQTE1dllZYlhSTk03ME1EbGNZMndkb0FxZ2NjUTh5YkFvcnhNM2hrcXFIcVBVMmxIc2pHUQ?oc=5\" target=\"_blank\">Weight loss biotech gets $70M, snags Amgen's obesity commercial leader as CEO</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Endpoints News</font>",
      "published": "2025-12-11T12:00:00+00:00",
      "source": "Endpoints News"
    }
  ],
  "product_launches": [
    {
      "title": "Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5\" target=\"_blank\">Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-09-10T07:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-16T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen Launches AmgenNow Direct-to-Consumer Platform to Enhance Product Accessibility - geneonline.com",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPTHNGUk81UGpwMnlTblZxZTBvRjhlMGNURTJPSHBxREhqUmJxYi0xQ1JUcnhLVXplekRjVUZhdkkzRTFJM3RQQ1lleDZPNmJ4TVVONldPNDRFRTJ4SV9SX0VTQkpYVklrcUxvc2s2XzlYYmhvMnRvczVjcmRBOFhPSlFpdTRYMWFDY1RwUU15SndhLXNDZ0gtUkhPYlNTaElMdXZTZTVDVHEzZ2xOd1ZIYjJR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxPTHNGUk81UGpwMnlTblZxZTBvRjhlMGNURTJPSHBxREhqUmJxYi0xQ1JUcnhLVXplekRjVUZhdkkzRTFJM3RQQ1lleDZPNmJ4TVVONldPNDRFRTJ4SV9SX0VTQkpYVklrcUxvc2s2XzlYYmhvMnRvczVjcmRBOFhPSlFpdTRYMWFDY1RwUU15SndhLXNDZ0gtUkhPYlNTaElMdXZTZTVDVHEzZ2xOd1ZIYjJR?oc=5\" target=\"_blank\">Amgen Launches AmgenNow Direct-to-Consumer Platform to Enhance Product Accessibility</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">geneonline.com</font>",
      "published": "2025-10-08T21:06:00+00:00",
      "source": "geneonline.com"
    },
    {
      "title": "3 major patent losses this year — and a key strategy to fill the gaps - Pharma Voice",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5\" target=\"_blank\">3 major patent losses this year — and a key strategy to fill the gaps</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Pharma Voice</font>",
      "published": "2025-07-21T07:00:00+00:00",
      "source": "Pharma Voice"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-09-08T07:00:00+00:00",
      "source": "simplywall.st"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-12-12",
      "close": 317.739990234375
    },
    "history": [
      {
        "date": "2025-12-04",
        "close": 340.1600036621094
      },
      {
        "date": "2025-12-05",
        "close": 329.8900146484375
      },
      {
        "date": "2025-12-08",
        "close": 321.2300109863281
      },
      {
        "date": "2025-12-09",
        "close": 313.8500061035156
      },
      {
        "date": "2025-12-10",
        "close": 315.3800048828125
      },
      {
        "date": "2025-12-11",
        "close": 317.3800048828125
      },
      {
        "date": "2025-12-12",
        "close": 317.739990234375
      }
    ],
    "name": "Amgen Inc."
  }
}